Table: Kaken Pharmaceutical -2019/20 group results

KAKEN PHARMACEUTICAL

22/05/2020 06:30

May 22 (Reuters)- 
          Kaken Pharmaceutical Co Ltd 
          CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                 Year ended      Year ended       Year to       NEXT   
              Mar 31, 2020    Mar 31, 2019   Mar 31, 2021     YEAR     
                 LATEST         YEAR-AGO        COMPANY      COMPANY   
                 RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales           89.23           94.17          82.90        41.00    
               (-5.2 pct)      (-4.3 pct)     (-7.1 pct)    (-9.2 pct) 
  Operating       26.51           24.59          20.80        10.90    
               (+7.8 pct)      (-10.6 pct)    (-21.5 pct)  (-20.7 pct) 
  Recurring       26.95           24.97          21.20        11.10    
               (+7.9 pct)      (-10.3 pct)    (-21.3 pct)  (-20.3 pct) 
  Net
  Net             19.37           17.78          15.00         7.90    
               (+9.0 pct)      (-6.7 pct)     (-22.6 pct)  (-17.3 pct) 
  EPS          494.89 yen      445.78 yen     385.43 yen    203.00 yen 
  Ann Div      150.00 yen      150.00 yen     150.00 yen               
  -Q2 Div       75.00 yen       75.00 yen      75.00 yen               
  -Q4 Div       75.00 yen       75.00 yen      75.00 yen               
  
  NOTE - Kaken Pharmaceutical Co Ltd.
  *Second Net profit row denotes profit attributable to owners ofthe parent 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4521.T